Baba Ramdev’s sermons on Patanjali’s cure-all drugs are flirting with the law
The yoga tycoon’s endorsement of Patanjali products as cures for chronic conditions raises ethical and legal questions.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
$99 for one year
More in Chaos
You may also like
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
For Sun Pharma’s Dilip Shanghvi, specialty drugs remain the magic bullet
Specialty drugs are fast becoming a lucrative market globally. And India’s largest drugmaker has done well to make the most of this opportunity so far. But it’s too soon to rest easy.
Can India finally rein in misleading claims in advertisements?
The Supreme Court has mandated all advertisers to submit self-declarations certifying that their ads had no bogus claims. Easier said than implemented.
